Is Vertex Pharmaceuticals Incorporated (VRTX) Undervalued?
Based on the current stock price of $462.90 and a P/E ratio of 32.58,Vertex Pharmaceuticals Incorporated has a PEG ratio of .
The Short Answer:
Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of , VRTX appears to be fairly valued relative to its growth rate of %.
Based on a PEG ratio of 0.00.
Compare VRTX vs Competitors
Use the calculator below to see how VRTX stacks up against other stocks in the same industry.
How we analyzed VRTX
We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 32.58and dividing it by the annual growth rate of %.
PEG = 32.58 (P/E) ÷ (Growth) =
Frequently Asked Questions about VRTX
What is the current PEG Ratio for Vertex Pharmaceuticals Incorporated (VRTX)?+
The current PEG Ratio for Vertex Pharmaceuticals Incorporated is N/A. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.
Is VRTX stock undervalued right now?+
Based on the PEG ratio of N/A, Vertex Pharmaceuticals Incorporated appears to be fairly valued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.
What is the PEGY Ratio for VRTX?+
The PEGY ratio for Vertex Pharmaceuticals Incorporated is N/A. This metric accounts for dividend yield (0.00%), providing a more complete valuation picture.